Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Microbiology and Immunology|January 24, 2007
Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytesKen-ichi Abe, Akito Nozaki, Kazushi Tamura, et al.
Plos One|October 12, 2013
Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA ReplicationYouki Ueda, Midori Takeda, Kyoko Mori, et al.
Plos One|September 12, 2013
New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replicationYouki Ueda, Midori Takeda, Kyoko Mori, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2011
Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis CMasanori Ikeda, Yoshinari Kawai, Kyoko Mori, et al.
Hepatology (Baltimore, Md.)|June 4, 2009
Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinaseMasahiko Yano, Masanori Ikeda, Ken-ichi Abe, et al.
British Journal of Haematology|November 20, 2002
Specificity of polymerase chain reaction-based clonality analysis of immunoglobulin heavy chain gene rearrangement for the detection of bone marrow infiltrate in B-cell lymphoma-associated haemophagocytic syndromeKensuke Kojima, Kinuyo Kaneda, Masaki Yasukawa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2010
Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon-α in vitroFusao Ikeda, Hiromichi Dansako, Go Nishimura, et al.
Cell Reports|February 16, 2024
Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironmentWenhao Zhou, Shusuke Kawashima, Takamasa Ishino, et al.
Biochemistry and Biophysics Reports|July 20, 2018
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251Youki Ueda, Weilin Gu, Hiromichi Dansako, et al.
International Journal of Cancer|August 23, 2023
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapiesNaoya Kemmotsu, Kiichiro Ninomiya, Kei Kunimasa, et al.
Pageof 8